STVOLOGEN®
As a result of our research, we have designed and developed peptidomimetics orally acting selectively on hematopoietic stem cells similar to a linear precursor parenterally.
Based on the leading cyclopeptide alanyl-gamma-glutamyl-tryptophan (“Stvologen»), we developed the novel biologically active food supplement Stvologen®.
Introduction into the market of Stvologen® opens the new era of safe peptide regulation body-own stem cells. Furthermore, it allows claiming the new perspectives – application of “endogenous” cell therapy by stem cells.